PRESS-RELEASE ·Filed Oct 15, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Myriad Genetics, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Key Facts
- Myriad Genetics, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3382117 |
11 reports for MYGN
75% Hit rate @ T+1 Went positive at some point 3 of 4 best @ T+5▲ +13.54%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $6.02 | awaiting T+1 | awaiting T+1 | $6.29 (+4.49%) |
Oct 20, 2026 7d ago | 8-K | $5.54 $5.57 | ▲ +0.54% | ▲ +0.02% | $6.29 (+13.54%) |
Oct 15, 2026 12d ago | Press Release | $3.98 | awaiting T+1 | awaiting T+1 | $6.29 (+58.04%) |
Oct 9, 2026 18d ago | 8-K | $4.20 $4.08 | ▼ −2.86% | ▼ −2.85% | $6.29 (+49.76%) |
Sep 16, 2026 5w ago | 8-K | $3.86 $4.14 | ▲ +7.25% | ▲ +6.12% | $6.29 (+62.95%) |
Sep 16, 2026 5w ago | Press Release | $3.86 $4.14 | ▲ +7.25% | ▲ +6.12% | $6.29 (+62.95%) |
Jul 30, 2026 12w ago | Press Release | $2.86 $3.02 | ▼ −5.59% | ▼ −4.17% | $6.29 (−119.93%) |
May 27, 2026 21w ago | Press Release | $3.93 $4.22 | ▲ +7.38% | ▲ +6.83% | $6.29 (+60.05%) |
Mar 17, 2026 32w ago | Press Release | $4.64 $4.75 | ▲ +2.37% | ▲ +2.64% | $6.29 (+35.56%) |
Feb 28, 2026 34w ago | Institutional Cluster | $5.01 $5.29 | ▲ +5.59% | ▲ +6.50% | $6.29 (+25.55%) |
Showing 10 of 11
US Market Status
Market Closed · Opens in 2h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers